advertisement

Topcon

Abstract #53919 Published in IGR 15-2

Canadian Journal of Ophthalmology Lecture: Translational research advances in glaucoma neuroprotection

Tsai JC
Canadian Journal of Ophthalmology 2013; 48: 141-145


Given that glaucoma is a disease of the central nervous system, there must be greater emphasis and focus on developing intraocular pressure-independent therapies. In addition, scientific research investigating the role of sustained drug delivery is critical for advancing the field. Exciting innovation will require close collaboration and full integration of clinical and basic research efforts. Thus, translational research advances in neuroprotection may lead to future development of truly revolutionary therapies for glaucoma (e.g., neuroregeneration).

Department of Ophthalmology and Visual Science, Yale University School of Medicine, New Haven, Conn. Electronic address: james.tsai@yale.edu.

Full article

Classification:

11.8 Neuroprotection (Part of: 11 Medical treatment)



Issue 15-2

Change Issue


advertisement

Oculus